$2.87 -0.08 (-2.71%)
7/2/2009 4:00 PM

Ligand Pharmaceuticals, Inc. (LGND)

CAPS Rating: 3 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Current Price $2.87 Mkt Cap $334.24M
Open $0.00 P/E Ratio 0.00
Prev. Close $2.95 Div. (Yield) N/A (N/A)
Daily Range $2.83 - $2.93 Volume 0
52-Wk Range $1.10 - $3.82 Avg. Daily Vol. 0

LGND News and Articles

All stories about LGND

Caps

How do you think LGND will perform vs the S&P 500?

Add Stock to Watchlist

All Members

111 Outperform
18 Underperform
 

All-Star Members

45 Outperform
5 Underperform
 

Wall Street

5 Outperform
1 Underperform
 

Top LGND Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.57)
Submitted April 14, 2009

I've been looking for a bigger pullback in Ligand given weak knees in the past but I'm getting tired of standing on the sidelines as the company continues to progress its pipeline. Mixed news on Fablyn since my last pitch - a Complete Response from… More

0 Comments | Reply | Report this Post

ImmortalThanos (< 20)
Submitted February 28, 2008

Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.

0 Comments | Reply | Report this Post
LGND VS S&P 500 (SPY)

Fools bullish on LGND are also bullish on:

Fools bearish on LGND are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about LGND.

Recs

0
Member Avatar bendrt (81.65) Submitted: 5/1/2009 10:27:34 AM : Outperform Start Price: $2.99 LGND Score: -6.72

Ligand has a number of good partnerships with strong pharma companies and they seem to have several good products in the pipeline. Buzz is about that Ligand is a potential target for acquisition but that's just hearsay; nevertheless, I think they could do quite well. Lots of inside ownership. I'll wait until the May 6 conference call and then make a purchasing decision.

Report this Post 1 Comment | Reply | Permalink

Recs

0
Member Avatar ilovestocks85 (96.32) Submitted: 4/21/2009 4:44:21 PM : Outperform Start Price: $2.79 LGND Score: -4.25

Accumulate under $3.

Potential buy-out target.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar tixareforkids (98.59) Submitted: 4/15/2009 1:25:12 PM : Outperform Start Price: $2.85 LGND Score: -5.73

zz

Report this Post 0 Comments | Reply | Permalink
View All 18 Pitches »

Leaderboard

Find the members with the highest scoring picks in LGND.

Score Leader

yeahbuddy

yeahbuddy (< 20) Score: +65.84

The Score Leader is the member with the highest score across all their picks in LGND.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. benes27 61.55 5/28/2008 Outperform 3M $2.28 +25.88% -35.18% +61.06
greenretriever 47.81 5/28/2008 1/13/2009 Outperform 3M $2.30 +24.78% -35.45% +60.24
ramoses 40.38 5/29/2008 Outperform 3Y $2.30 +24.78% -35.40% +60.19
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. gillet01 73.64 5/29/2008 Outperform 5Y $2.30 +24.78% -35.40% +60.19
mdjuranovic < 20 10/10/2008 Outperform NS $1.77 +62.15% +3.52% +58.63
kalderso 79.02 11/25/2008 Outperform NS $1.98 +44.95% +2.79% +42.16
Unbeleavabe 80.74 10/20/2008 Outperform NS $2.16 +32.87% -6.90% +39.77
pdt24 < 20 11/21/2008 Outperform 5Y $1.79 +60.34% +20.58% +39.75
pick1998 90.51 1/26/2009 Outperform NS $2.01 +42.79% +7.44% +35.34 1 Comment
exrktscientist 96.75 1/28/2009 Outperform 3Y $2.10 +36.67% +3.95% +32.72
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackMerrimanCo < 20 2/12/2009 Outperform NS $2.52 +13.89% +9.30% +4.59
TrackOppenheimer 87.12 1/22/2009 Outperform NS $2.14 +34.11% +8.97% +25.15
TrackRodmanRen 81.15 11/26/2008 Outperform NS $1.79 +60.34% +6.47% +53.86
TrackSusquehanna 73.37 12/7/2007 Outperform NS $4.81 -40.33% -40.69% +0.36
TrackJimCramer 64.82 1/8/2007 Underperform 3W $8.53 -66.36% -36.38% +29.98
TrackBroadpoint.AmTech 79.36 9/11/2006 Outperform NS $7.98 -64.03% -30.84% -33.19

Featured Broker Partners